Rowland, Katherine J <br/><br/>
The "cryptic" mechanism of action of glucagon-like peptide-2.  [electronic resource] 

 -  American journal of physiology. Gastrointestinal and liver physiology  Jul 2011 
 - G1-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1522-1547 
<br/><br/><label>Standard No.: </label>10.1152/ajpgi.00039.2011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Cell Proliferation--drug effects<br/>Cell Transformation, Neoplastic--chemically induced<br/>Colonic Neoplasms--chemically induced<br/>Fibroblast Growth Factor 7--metabolism<br/>Glucagon-Like Peptide 2--adverse effects<br/>Glucagon-Like Peptide-2 Receptor<br/>Humans<br/>Intestinal Mucosa--metabolism<br/>Intestines--drug effects<br/>Mice<br/>Nitric Oxide--metabolism<br/>Rats<br/>Receptors, Glucagon--agonists<br/>Signal Transduction--drug effects<br/>Somatomedins--metabolism<br/>Stem Cells--drug effects<br/>Vasoactive Intestinal Peptide--pharmacology